[ <sup>18</sup> F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity
Woo-Suk Kim(University of California, Los Angeles), Caius G. Radu(APLA Health), Ken Herrmann(Essen University Hospital), Anthony E. Cabebe(University of California, Los Angeles), Raymond M. Gipson(University of California, Los Angeles), Roger Slavik(University of California, Los Angeles), Soumya Poddar(University of California, Los Angeles), Arnon Lavie(Veterans Health Administration), Thotsophon Taechariyakul(University of California, Los Angeles), Saman Sadeghi(University of California, Los Angeles), Timothy R. Donahue(University of California, Los Angeles), Jason T. Lee(University of California, Los Angeles), Evan R. Abt(Sylvester Comprehensive Cancer Center), Dalton Steele(University of California, Los Angeles), Jimmy Bazzy(University of California, Los Angeles), Juno S. Van Valkenburgh(University of California, Los Angeles), Kym F. Faull(University of California, Los Angeles), Owen N. Witte(Howard Hughes Medical Institute), Wayne R. Austin, Wei Liu(Hebei Medical University), Michael E. Phelps(National Academy of Engineering), Johannes Czernin(University of California, Los Angeles), Harvey R. Herschman(University of California, Los Angeles), Joseph Capri(University of California, Los Angeles), Thuc Le(University of California, Los Angeles), Shahriar Yaghoubi(Stanford Medicine), Nhu T. Uong(University of California, Los Angeles)
Cited by 88
Related Papers
Quantitation in Positron Emission Computed Tomography
|Journal of Computer Assisted Tomography|1979|1.2k
Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
|Journal of Clinical Oncology|2016|1k
Positron Emission Tomography in Evaluation of Dementia
|JAMA|2001|952